Locations:
Search IconSearch

Tag: ocrelizumab

health worker preparing infusion of injectable drug

Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

intravenous infusion line

Shorter Ocrelizumab Infusion Time for Multiple Sclerosis Does Not Affect Safety Profile

No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad